Search results for: 'risk based privacy care'
- Related search terms
- care management solutions market by components
- based on a9aa pfm1 market research
- privacy healthcare services market
- based on a9aa pfm2 market research
- based ad recovery market size
-
20 Mar 2019  |  North America  |  Market Research
2019 Predictions of the Global Life Sciences Industry
As Novel Technologies Find Traction, Industry Focus Will Shift Towards Successful Monetization to Deliver Value-based Care
he global life science industry is in a state of flux. While the recent years have seen the advent of multiple novel technologies, such as in-vitro diagnostics (IVD), CRISPR-Cas9, virtual clinical trials, and liquid biopsy, the industry stands at a crossroad with challenges in scaling-up and commercializing such technologies. In addition, companies...
$1,500.00
Special Price $1,125.00 save 25 %
-
04 Sep 2018  |  North America  |  Market Research
Digital Transformation in the Pharmaceuticals Industry—Companies-to-Action, 2018
Value-based Care, Patient Data Digitization, and Collaborative Technology Deployment Offer Investment Opportunities
The pharmaceutical industry today is in a state of flux as it tries to maintain a delicate balance between the need for novel blockbuster drugs and the need for improved operational efficiencies in an increasingly competitive market space. As healthcare is becoming increasingly democratized, patients are emerging as key decision makers—digitally en...
$3,000.00
Special Price $2,250.00 save 25 %
-
30 Jun 2021  |  North America  |  Market Research
US & EU Direct-to-consumer Genetic Testing Market, Key Trends & Growth Opportunities
Telegenetic Counseling to Revolutionize Access to Patient Care
In 2003, the first human genome sequence was produced, with a production cost between $500 million and $1 billion. However, since 2008, when next-generation sequencing (NGS) approaches entered the research setting, there has been a significant decline in sequencing costs. These approaches allow either the whole genome (via whole-genome sequencing [...
$2,450.00
Special Price $1,837.50 save 25 %
-
05 Feb 2021  |  North America  |  Market Research
Shifting Spotlight from Product- to Value-based Outcomes Intensifies Growth in the US Real-world Evidence IT Solutions Market
Early-stage R&D and Commercial Applications Fuel the Growth Pipeline
The US healthcare industrys transition to a patient-centric model is moving rapidly with focus on outcomes and value; however, drug prices have increased and pharmaceutical research and development (R&D) productivity is at its lowest. The healthcare industry and IT solutions providers are finding real-world evidence (RWE) as a potential solution to...
$4,950.00
Special Price $3,712.50 save 25 %
-
27 Aug 2019  |  North America  |  Market Research
Growth Opportunities in the Neurodegenerative Disorder Therapeutics Market, Forecast to 2024
Digital Solutions will Spark Integrated Development Approaches and Successful Adjunctive Therapies for Disease Modification
As one lives longer, one needs to increasingly battle age-related disorders. Neurodegenerative disorders are the most worrisome, because they impact millions of people around the world and lack any curative therapy. While companies continue their search, they are also battling declining revenues from marketed products used to manage symptoms. Heavy...
$4,950.00
Special Price $3,712.50 save 25 %
-
08 Mar 2022  |  North America  |  Market Outlook
Global Pharmaceuticals Outlook, 2022
The Digitalization of the Pharmaceuticals Value Chain is Opening up New Growth Opportunities for Stakeholders
Frost & Sullivan offers an outlook for the global pharmaceuticals market for 2022-2026, including emerging trends and growth opportunities. Prioritizing booster doses over initial dose coverage is negatively impacting the global mitigation of the COVID-19 pandemic, which is resulting in severe implications on health and social and economic well-bei...
$4,950.00
Special Price $3,712.50 save 25 %
-
09 Apr 2018  |  North America  |  Market Outlook
Global Life Sciences Industry Outlook, 2018
Global Life Sciences Industry to Reach $1.5 T by 2022, Driven by Innovative Google, Amazon, Facebook, Apple (GAFA) Partnerships and R&D IT Investments
The global life sciences industry is onto a rocking start with the surge in CEO confidence from US tax reforms, rollicking equity markets and strengthening the global economy. Healthcare digitization, democratization creating explosion in patient data, emergence of value-based reimbursement models, and healthcare consumerism shifting the risk from ...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Dec 2020  |  North America  |  Market Research
I-O Therapy Combinations Spurring Growth of the Global Immuno-oncology Market
Upcoming Product Launches in Adoptive Cell Therapy Segment Hold Future Growth Potential
This study explores the global immuno-oncology (I-O) markets evolution from 2020 to 2025. An extensive analysis is provided on the growth opportunities envisioned by Frost & Sullivan to help stakeholders leverage their momentum and disrupt the market by offering best-in-class solutions. The study considers oncology agents for which the immune syst...
$4,950.00
Special Price $3,712.50 save 25 %
-
19 Feb 2021  |  North America  |  Market Research
Regulatory and Infrastructure Reforms in India and China Catalyzing the Asian Specialty Generics Market
High Unmet Needs in Niche Oncology Indications will Drive Future Growth Potential
Frost & Sullivans Transformational Health team provides critical insights into the Asian specialty generics market with this research service, highlighting growth opportunities, selected countries biopharmaceutical environment, and significant R&D, regulatory, and infrastructure reforms influencing its growth. The report examines similarities and c...
$2,450.00
Special Price $1,837.50 save 25 %
-
07 Mar 2019  |  North America  |  Market Research
Mergers and Acquisitions in the Global Life Sciences Industry, 2018
M&As for Growth in Patient Engagement, Artificial Intelligence and Big Data Analytics are Driving Greater Vertical Integration
The Healthcare industry has witnessed some of the largest mega-mergers in 2018 – mergers on the provider as well as the payer ends. While this has the potential to bring a shift in power centers in the ecosystem, each stakeholder has relied heavily on inorganic growth to maintain their stronghold. This Mergers and Acquisitions in Life Sciences Indu...
$3,000.00
Special Price $2,250.00 save 25 %